Compare $APRE vs $BOLT | Chartloom

Compare

$APRE vs $BOLT

Aprea Therapeutics Inc · Bolt Biotherapeutics Inc

APRE

Aprea Therapeutics Inc

BOLT

Bolt Biotherapeutics Inc

Compare $APRE vs $BOLT

Comparing Aprea Therapeutics Inc and Bolt Biotherapeutics Inc

APREAprea Therapeutics Inc

BOLTBolt Biotherapeutics Inc

APREAprea Therapeutics Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-99.4%

YTD performance

-29.1%

52W performance

-57.8%

FCF yield

-162.8%

BOLTBolt Biotherapeutics Inc

Market cap

$8M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

12.8%

YTD performance

-29.0%

52W performance

-35.8%

FCF yield

-399.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APRE

BOLT

Detailed metrics comparison

APRE

Aprea Therapeutics Inc

BOLT

Bolt Biotherapeutics Inc

Market Cap

APRE$7M

BOLT$8M

Enterprise Value

APRE$-34M

BOLT$-5M

Price

APRE$0.60

BOLT$4.11

P/E Ratio

APREN/A

BOLTN/A

P/S Ratio

APRE1,438.94x

BOLT1.68x

EV/Sales

APRE-6,490.56x

BOLT-1.06x

EV/EBITDA

APRE0.00x

BOLT0.00x

P/B Ratio

APRE0.22x

BOLT0.53x

P/FCF Ratio

APREN/A

BOLTN/A

EV/FCF

APRE2.77x

BOLT0.16x

PEG Ratio

APREN/A

BOLTN/A

Forward P/E (NTM)

APREN/A

BOLTN/A

Forward P/S (NTM)

APREN/A

BOLTN/A

Revenue (TTM)

APRE$5K

BOLT$5M

Revenue Growth (YoY)

APRE-99.4%

BOLT12.8%

Forward Rev Growth

APRE445.8%

BOLT1650.0%

Gross Margin (TTM)

APRE0.0%

BOLT0.0%

Operating Margin (TTM)

APRE0.0%

BOLT0.0%

EBITDA Margin (TTM)

APRE-253869.2%

BOLT-586.3%

Net Margin (TTM)

APRE-236676.9%

BOLT-611.5%

FCF Margin (TTM)

APRE-234296.2%

BOLT-671.0%

Net Income (TTM)

APRE$-12M

BOLT$-29M

FCF (TTM)

APRE$-12M

BOLT$-32M

EPS (TTM)

APRE-$0.23

BOLT-$17.00

ROE (TTM)

APRE-4630.0%

BOLT-12623.0%

ROA (TTM)

APRE-4097.0%

BOLT-5470.0%

ROIC (TTM)

APRE-4630.0%

BOLT-12623.0%

Cash

APRE$41M

BOLT$13M

Debt

APRE$0

BOLT$0

Net Cash/Debt

APRE$41M

BOLT$13M

Current Ratio (TTM)

APRE13.55x

BOLT2.61x

Quick Ratio (TTM)

APRE13.33x

BOLT2.26x

Debt/Equity (TTM)

APRE0.00x

BOLT0.00x

Debt/Assets (TTM)

APRE0.0%

BOLT0.0%

Interest Coverage (TTM)

APREN/A

BOLTN/A

Net Debt/EBITDA (TTM)

APRE0.00x

BOLT0.00x

Beta

APRE-1.23

BOLT0.97

52W Performance

APRE-57.8%

BOLT-35.8%

YTD Performance

APRE-29.1%

BOLT-29.0%

% from 52W High

APRE-64.2%

BOLT-42.9%

% from 52W Low

APRE10.3%

BOLT32.6%

Asset Turnover (TTM)

APRE0.02x

BOLT0.09x

FCF Yield (TTM)

APRE-162.8%

BOLT-399.6%

Earnings Yield (TTM)

APRE-164.5%

BOLT-364.2%

Dividend Yield (TTM)

APREN/A

BOLTN/A

Rule of 40

APRE-234,395.5

BOLT-658.2

EV/GP/RG

APREN/A

BOLTN/A

Ticker research

View APRE research View BOLT research

Metric	APRE Aprea Therapeutics Inc	BOLT Bolt Biotherapeutics Inc
Market & Valuation
Market Cap	$7M	$8M
Enterprise Value	$-34M	$-5M
Price	$0.60	$4.11
P/E Ratio	N/A	N/A
P/S Ratio	1,438.94x	1.68x
EV/Sales	-6,490.56x	-1.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.22x	0.53x
P/FCF Ratio	N/A	N/A
EV/FCF	2.77x	0.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5K	$5M
Revenue Growth (YoY)	-99.4%	12.8%
Forward Rev Growth	445.8%	1650.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-253869.2%	-586.3%
Net Margin (TTM)	-236676.9%	-611.5%
FCF Margin (TTM)	-234296.2%	-671.0%
Net Income (TTM)	$-12M	$-29M
FCF (TTM)	$-12M	$-32M
EPS (TTM)	-$0.23	-$17.00
ROE (TTM)	-4630.0%	-12623.0%
ROA (TTM)	-4097.0%	-5470.0%
ROIC (TTM)	-4630.0%	-12623.0%
Financial Health
Cash	$41M	$13M
Debt	$0	$0
Net Cash/Debt	$41M	$13M
Current Ratio (TTM)	13.55x	2.61x
Quick Ratio (TTM)	13.33x	2.26x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.23	0.97
52W Performance	-57.8%	-35.8%
YTD Performance	-29.1%	-29.0%
% from 52W High	-64.2%	-42.9%
% from 52W Low	10.3%	32.6%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.09x
FCF Yield (TTM)	-162.8%	-399.6%
Earnings Yield (TTM)	-164.5%	-364.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-234,395.5	-658.2
EV/GP/RG	N/A	N/A
Ticker research	View APRE research	View BOLT research

Valuation

P/S Ratio

BOLT

1.68x

APRE

1,438.94x

EV/FCF

BOLT

0.16x

APRE

2.77x

Growth & revenue

Revenue Growth TTM

BOLT

12.8%

APRE

-99.4%

Forward Revenue Growth

BOLT

1650.0%

APRE

445.8%

Profitability & performance

Gross Margin

APRE

0.0%

BOLT

0.0%

ROE

APRE

-4630.0%

BOLT

-12623.0%

FCF Yield %

APRE

-162.8%

BOLT

-399.6%

52-Week Performance

BOLT

-35.8%

APRE

-57.8%

Detailed metrics comparison

APRE

Aprea Therapeutics Inc

BOLT

Bolt Biotherapeutics Inc

Market Cap

APRE$7M

BOLT$8M

Enterprise Value

APRE$-34M

BOLT$-5M

Price

APRE$0.60

BOLT$4.11

P/E Ratio

APREN/A

BOLTN/A

P/S Ratio

APRE1,438.94x

BOLT1.68x

EV/Sales

APRE-6,490.56x

BOLT-1.06x

EV/EBITDA

APRE0.00x

BOLT0.00x

P/B Ratio

APRE0.22x

BOLT0.53x

P/FCF Ratio

APREN/A

BOLTN/A

EV/FCF

APRE2.77x

BOLT0.16x

PEG Ratio

APREN/A

BOLTN/A

Forward P/E (NTM)

APREN/A

BOLTN/A

Forward P/S (NTM)

APREN/A

BOLTN/A

Revenue (TTM)

APRE$5K

BOLT$5M

Revenue Growth (YoY)

APRE-99.4%

BOLT12.8%

Forward Rev Growth

APRE445.8%

BOLT1650.0%

Gross Margin (TTM)

APRE0.0%

BOLT0.0%

Operating Margin (TTM)

APRE0.0%

BOLT0.0%

EBITDA Margin (TTM)

APRE-253869.2%

BOLT-586.3%

Net Margin (TTM)

APRE-236676.9%

BOLT-611.5%

FCF Margin (TTM)

APRE-234296.2%

BOLT-671.0%

Net Income (TTM)

APRE$-12M

BOLT$-29M

FCF (TTM)

APRE$-12M

BOLT$-32M

EPS (TTM)

APRE-$0.23

BOLT-$17.00

ROE (TTM)

APRE-4630.0%

BOLT-12623.0%

ROA (TTM)

APRE-4097.0%

BOLT-5470.0%

ROIC (TTM)

APRE-4630.0%

BOLT-12623.0%

Cash

APRE$41M

BOLT$13M

Debt

APRE$0

BOLT$0

Net Cash/Debt

APRE$41M

BOLT$13M

Current Ratio (TTM)

APRE13.55x

BOLT2.61x

Quick Ratio (TTM)

APRE13.33x

BOLT2.26x

Debt/Equity (TTM)

APRE0.00x

BOLT0.00x

Debt/Assets (TTM)

APRE0.0%

BOLT0.0%

Interest Coverage (TTM)

APREN/A

BOLTN/A

Net Debt/EBITDA (TTM)

APRE0.00x

BOLT0.00x

Beta

APRE-1.23

BOLT0.97

52W Performance

APRE-57.8%

BOLT-35.8%

YTD Performance

APRE-29.1%

BOLT-29.0%

% from 52W High

APRE-64.2%

BOLT-42.9%

% from 52W Low

APRE10.3%

BOLT32.6%

Asset Turnover (TTM)

APRE0.02x

BOLT0.09x

FCF Yield (TTM)

APRE-162.8%

BOLT-399.6%

Earnings Yield (TTM)

APRE-164.5%

BOLT-364.2%

Dividend Yield (TTM)

APREN/A

BOLTN/A

Rule of 40

APRE-234,395.5

BOLT-658.2

EV/GP/RG

APREN/A

BOLTN/A

Ticker research

View APRE research View BOLT research

Metric	APRE Aprea Therapeutics Inc	BOLT Bolt Biotherapeutics Inc
Market & Valuation
Market Cap	$7M	$8M
Enterprise Value	$-34M	$-5M
Price	$0.60	$4.11
P/E Ratio	N/A	N/A
P/S Ratio	1,438.94x	1.68x
EV/Sales	-6,490.56x	-1.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.22x	0.53x
P/FCF Ratio	N/A	N/A
EV/FCF	2.77x	0.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5K	$5M
Revenue Growth (YoY)	-99.4%	12.8%
Forward Rev Growth	445.8%	1650.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-253869.2%	-586.3%
Net Margin (TTM)	-236676.9%	-611.5%
FCF Margin (TTM)	-234296.2%	-671.0%
Net Income (TTM)	$-12M	$-29M
FCF (TTM)	$-12M	$-32M
EPS (TTM)	-$0.23	-$17.00
ROE (TTM)	-4630.0%	-12623.0%
ROA (TTM)	-4097.0%	-5470.0%
ROIC (TTM)	-4630.0%	-12623.0%
Financial Health
Cash	$41M	$13M
Debt	$0	$0
Net Cash/Debt	$41M	$13M
Current Ratio (TTM)	13.55x	2.61x
Quick Ratio (TTM)	13.33x	2.26x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.23	0.97
52W Performance	-57.8%	-35.8%
YTD Performance	-29.1%	-29.0%
% from 52W High	-64.2%	-42.9%
% from 52W Low	10.3%	32.6%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.09x
FCF Yield (TTM)	-162.8%	-399.6%
Earnings Yield (TTM)	-164.5%	-364.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-234,395.5	-658.2
EV/GP/RG	N/A	N/A
Ticker research	View APRE research	View BOLT research